AmerisourceBergen 2016 Conference Presentation

AmerisourceBergen's December 2016 investor conference presentation covering the company's core drug distribution business and specialty pharmaceutical services. The presentation highlights 15 years of post-merger performance with 17% adjusted EPS CAGR and discusses the company's market leadership in physician-administered specialty products.